Anti-Viral Drugs Market with Current Trends Analysis, 2016-2026 Anti-Viral Drugs Market with Current Trends Analys | Page 5

Report
Description
Report Description
• Herpes antivirals
• Hepatitis-B antivirals
• Influenza antivirals
• Others (Pneumonia, Flu, etc.)
Based on end user, the global anti-viral drugs market is segmented into the following:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1951
Anti-viral Drugs Market: Overview

The generic market of anti-viral drugs is presently dominated by products such as
didanosine, zidovudine, lamivudine and stavudine. The biggest driver of overall anti-viral
drugs market is Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome
(HIV/AIDS) therapeutic sales which accounted for more than half the share of the market
2010. At the end of 2012, 9.7 million people in low-income and middle-income countries
were on antiretroviral treatment (ART). According to WHO, in 2012, number of patients
on ART increased by 1.6 Mn, the largest increase in one year. Nearly four out of five